Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2023
Daniel Herranz, PharmD, PhD
Unleashing the therapeutic potential of dietary histidine restriction in T-ALL
Read More
2023
David Langenau, PhD
Reversing therapy resistance in pediatric rhabdomyosarcoma
Read More
2023
Xiao-Nan Li, M.D., Ph.D.
Targeting Root Cells of Therapy Resistance in Pediatric Diffuse High-Grade Gliomas
Read More
2023
Reshma Mahtani, DO
Helping Women of South Florida Understand and Access Breast Cancer Clinical Trials
Read More
2023
Eric Rellinger, M.D.
Aberrant Fucosylation Regulates Neuroblastoma Tumor-Associated Macrophage Recruitment and Polarization
Read More
2023
Joelle Straehla, MD
Resistance and sensitization mechanisms of nanoparticle delivery to pediatric diffuse midline glioma
Read More
2023
Asmin Tulpule, MD, PhD
Therapeutic targeting of DNA repair and residual disease in pediatric sarcoma
Read More
2023
Kathryn Weaver, PhD
Population Health Navigation: A Comprehensive Intervention to Increase Clinical Trial Participation
Read More
2022
Ken Hu, PhD
Identification of mechanisms by which the non-immune stroma controls immune cell infiltration...
Read More
2022
Derek Oldridge, MD, PhD
Deep profiling of the high-grade glioma immune microenvironment with cellular and spatial...
Read More
2022
Bingfei Yu, PhD
PAIR-seq: precise mapping of T cell specificity and fate in tumors
Read More
2022
Kathryn Weaver, PhD
Population Health Navigation: A Comprehensive Intervention to Increase Clinical Trial Participation
Read More
2022
Margot Lazow, MD
Identification of multimodal biomarkers of response, recurrence, and resistance to targeted therapy...
Read More
2022
Chrysothemis Brown, MD, PhD
Targeting novel early life antigen presenting cells for pediatric cancer immunotherapy
Read More
2022
Vida Henderson, PhD, PharmD
Applying Business Marketing Strategies to Improve Equity in Cancer Clinical Trials
Read More
2022
Claude Sirlin, MD
Screening Ultrasound for Early Detection of Liver Cancer
Read More